AN2 Therapeutics
our global health commitment an therapeutics an leadership team is committed to applying our know how to help solve some of the infections in global health intent is from sources such as public and private agencies and foundations to fund these efforts primarily through non dilutive funding the highest priority research with is currently conducting preclinical university global health an therapeutics i | AN2 Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
March 2022
Slide
25 of 27
Similar slides by AN2 Therapeutics
See diffirences between slides (animation)
Investor Presentation
August 2022
our global health commitment global health agreement partners an leadership team is committed to applying our know how to help solve some of the infections in global health intent is to fund these efforts primarily through non dilutive funding from sources such as public and private agencies and foundations the highest priority is currently conducting preclinical research with an university an therapeutics | AN2 Therapeutics
Related slides by other companies
Freshworks
Investor Presentation
October 2021
experienced global leadership team | Freshworks
9 Meters Biopharma
Investor Presentation
September 2022
leadership team am whey meters | 9 Meters Biopharma
Nextdoor
Investor Presentation
August 2023
experienced leadership team | Nextdoor
OpenText
Investor Presentation
November 2022
deeply talented and experienced leadership team | OpenText
Other recent decks by AN2 Therapeutics
See all presentations (2 decks)
Investor Presentation
August 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io